Jialin Wang
7 Weiwu Road
Zhengzhou, 450003, China
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes.
Journal: Cell cycle (Georgetown, Tex.)
Published: July 19, 2022
Identification of PYGL as a key prognostic gene of glioma by integrated bioinformatics analysis.
Journal: Future oncology (London, England)
Published: January 17, 2022
GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma.
Journal: Frontiers in oncology
Published: June 30, 2021
Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma.
Journal: Cancer cell international
Published: March 20, 2021
ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma.
Journal: Frontiers in genetics
Published: March 15, 2021
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.
Journal: Molecular medicine (Cambridge, Mass.)
Published: January 19, 2021
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value.
Journal: Molecular and clinical oncology
Published: January 11, 2021
ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma.
Journal: Frontiers in oncology
Published: September 30, 2020
Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells.
Journal: Cancer medicine
Published: August 13, 2020
Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.
Journal: Cell cycle (Georgetown, Tex.)
Published: May 22, 2020
Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma.
Journal: Oncology letters
Published: April 03, 2020
Last Updated: 09/26/2026